Gilead's Remdesivir Shows Fair Improvement In Moderate COVID-19 Patients Posted By: Unknown 20:57 Leave a Reply Gilead Sciences Inc on Monday reported that its antiviral drug remdesivir provided a modest benefit in patients with moderate COVID-19 given a five-day course of the treatment, while those who... from NDTV News - Latest https://ift.tt/36PjXS6 Tweet Share Share Share Share
0 comments: